RecruitingNot ApplicableNCT07666347

Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis


Sponsor

Tanta University

Enrollment

50 participants

Start Date

Jun 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the efficacy of intra-articular injection of Botulinum toxin and hyaluronic acid on pain in knee osteoarthritis.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Botulinum toxin type A and a drug called Hyaluronic acid for people with botox, hyaluronic acid, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyaluronic acid

Patients will be given intra-articular injection of 2 ml of hyaluronic acid into the joint space three times weekly.

DRUGBotulinum toxin type A

Patients will be given intra-articular injection of 100 units of Botulinum toxin type A, diluted with 5 ml of normal saline three times weekly.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07666347


Related Trials